Description
Opioid products need to include specific content within their RMP to address: the risk and uncertainties of opioid-related harms in Canada and other risks and uncertainties posed by the product, where warranted.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Submitting risk management plans draft guidance document: Opioid products | HTML | Open resource | |
| Submitting risk management plans draft guidance document: Opioid products | HTML | Open resource |